Description de l'entreprise
Cantel Medical Corp. (NYSE:CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. The company's products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, Cantel Medical Corp. provides technical service for its products.
Conseil d'administration & Conseil de surveillance
| PDG |
| George L. Fotiades |
| Conseil d'administration |
| Shaun M. Blakeman, Eric Moore, Greg Reny, Jean Casner, Jeff Mann, Ken Serota, Michael Drexel, Michael Mcgrath, Mike Spicer, Neil Blewitt, Peter Clifford, Seth Yellin, Terry Lubben |
| Conseil de surveillance |
| Charles M. Diker, Alan R. Batkin, Ann E. Berman, Anthony B. Evnin, Dr. Ronnie Myers, George L. Fotiades, Karen N. Prange, Laura Forese, MD, Mark N. Diker, Peter Pronovost, MD |
Données de l'entreprise
| Nom: |
Cantel Medical Corp. |
| Adresse: |
150 Clove Road, 9th Floor,Little Falls, New Jersey 07424-2139, USA |
| Téléphone: |
+1-973-890-7220 |
| Fax: |
+1-973-890-7270 |
| Courriel: |
info@cantelmedical.com
|
| Internet: |
www.cantelmedical.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/07 |
| Flotte libre: |
56.90% |
| IPO date: |
- |
